IL-11 regulates autoimmune demyelination

BT Gurfein, Y Zhang, CB López, AT Argaw… - The Journal of …, 2009 - journals.aai.org
BT Gurfein, Y Zhang, CB López, AT Argaw, A Zameer, TM Moran, GR John
The Journal of Immunology, 2009journals.aai.org
Current therapies for the autoimmune demyelinating disease multiple sclerosis (MS) target
inflammation, but do not directly address neuroprotection or lesion repair. Cytokines of the
gp130 family regulate survival and differentiation of both neural and immune cells, and we
recently identified expression of the family member IL-11 in active MS plaques. In this study,
we show that IL-11 regulates the clinical course and neuropathology of experimental
autoimmune encephalomyelitis, a demyelinating model that mimics many of the clinical and …
Abstract
Current therapies for the autoimmune demyelinating disease multiple sclerosis (MS) target inflammation, but do not directly address neuroprotection or lesion repair. Cytokines of the gp130 family regulate survival and differentiation of both neural and immune cells, and we recently identified expression of the family member IL-11 in active MS plaques. In this study, we show that IL-11 regulates the clinical course and neuropathology of experimental autoimmune encephalomyelitis, a demyelinating model that mimics many of the clinical and pathologic features of MS. Importantly, the effects of IL-11 are achieved via a combination of immunoregulation and direct neuroprotection. IL-11R-α-null (IL-11Rα−/−) mice displayed a significant increase in clinical severity and neuropathology of experimental autoimmune encephalomyelitis compared with wild-type littermates. Inflammation, demyelination, and oligodendrocyte and neuronal loss were all exacerbated in IL-11Ra−/− animals. Conversely, wild-type mice treated with IL-11 displayed milder clinical signs and neuropathology than vehicle-treated controls. In cocultures of murine myelin oligodendrocyte glycoprotein 35–55-specific CD4+ T lymphocytes and CD11c+ APCs, IL-11 treatment resulted in a significant decrease in T cell-derived effector cytokine production. This effect was generated via modulation of CD11c+ APC-mediated lymphocyte activation, and was associated with a decrease in the size of the CD11c+ cell population. Conversely, IL-11 strongly reduced apoptosis and potentiated mitosis in primary cultures of mouse oligodendrocyte progenitors. Collectively, these data reveal that IL-11 regulates inflammatory demyelination via a unique combination of immunoregulation and neuroprotection. IL-11 signaling may represent a therapeutic avenue to restrict CNS inflammation and potentiate oligodendrocyte survival in autoimmune demyelinating disease.
journals.aai.org